Skip Navigation

Publication Detail

Title: Patterns of cellular and HPV 16 methylation as biomarkers for cervical neoplasia.

Authors: Patel, Divya A; Rozek, Laura S; Colacino, Justin A; Van Zomeren-Dohm, Adrienne; Ruffin, Mack T; Unger, Elizabeth R; Dolinoy, Dana C; Swan, David C; Onyekwuluje, Juanita; DeGraffinreid, Cecilia R; Paskett, Electra D

Published In J Virol Methods, (2012 Sep)

Abstract: Aberrant promoter methylation of biologically relevant genes in cervical cancer and uneven CpG distribution within the human papillomavirus 16 (HPV 16) enhancer region have been reported. Cervical samples and questionnaires from 151 women screened for cervical cancer in Appalachian Ohio were analyzed. Methylation was measured by bisulfite sequencing in candidate gene sites in ESR1, DCC, p16, and LINE1 elements. Among 89 HPV 16-positive women, CpG sites in the E6 promoter and enhancer regions and the L1 region of the HPV 16 genome were measured. Methylation levels were compared by cervical cytology and HPV 16 status. HPV methylation was low regardless of cytology status, however E6 methylation was significantly higher in women with normal cytology. ESR1 and DCC methylation were significantly higher in HPV 16-positive women. Increased methylation at sites in the E6 promoter region was associated with lower odds of abnormal cytology. Increased methylation in candidate genes was associated with higher odds of abnormal cytology, particularly DCC region 2.4, DCC region 2.6, ESR1 region 3.2, and LINE1 site 1.2. HPV 16 genome CpG methylation was low except for the L1 region. In general, lower HPV 16 methylation and higher candidate gene methylation levels were associated with higher odds of abnormal cytology.

PubMed ID: 22664184 Exiting the NIEHS site

MeSH Terms: No MeSH terms associated with this publication

Back
to Top